Skip to main content

Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.

Publication ,  Conference
Kovach, AR; Linardic, CM
Published in: MOLECULAR CANCER RESEARCH
2020

Duke Scholars

Published In

MOLECULAR CANCER RESEARCH

EISSN

1557-3125

ISSN

1541-7786

Publication Date

2020

Volume

18

Issue

8

Start / End Page

26 / 26

Related Subject Headings

  • Oncology & Carcinogenesis
  • Developmental Biology
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kovach, A. R., & Linardic, C. M. (2020). Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. In MOLECULAR CANCER RESEARCH (Vol. 18, pp. 26–26).
Kovach, Alexander R., and Corinne M. Linardic. “Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.” In MOLECULAR CANCER RESEARCH, 18:26–26, 2020.
Kovach AR, Linardic CM. Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. In: MOLECULAR CANCER RESEARCH. 2020. p. 26–26.
Kovach, Alexander R., and Corinne M. Linardic. “Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.MOLECULAR CANCER RESEARCH, vol. 18, no. 8, 2020, pp. 26–26.

Published In

MOLECULAR CANCER RESEARCH

EISSN

1557-3125

ISSN

1541-7786

Publication Date

2020

Volume

18

Issue

8

Start / End Page

26 / 26

Related Subject Headings

  • Oncology & Carcinogenesis
  • Developmental Biology
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis